ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Biomarker Analysis Market Research Report 2025
Published Date: May 2025
|
Report Code: QYRE-Auto-18B14492
Home | Market Reports | Business & Industrial| Pharmaceuticals & Biotech
Global Biomarker Analysis Market Research Report 2023
BUY CHAPTERS

Global Biomarker Analysis Market Research Report 2025

Code: QYRE-Auto-18B14492
Report
May 2025
Pages:89
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
Bio Rad
Eurofins Scientific
Crown Bioscience
Meridian Bioscience
Thermo Fisher Scientific Inc
Siemens Healthineers
Roche Molecular Diagnostics
Abbott Laboratories
Becton Dickinson and Company
Eve Technologies
Hybrigenics Services
Luminex Corp
Qiagen NV
Agilent/Dako
Fluidic Analytics

Biomarker Analysis Market Size

The global market for Biomarker Analysis was valued at US$ 4275 million in the year 2024 and is projected to reach a revised size of US$ 8788 million by 2031, growing at a CAGR of 11.0% during the forecast period.

Biomarker Analysis Market

Biomarker Analysis Market

Biomarker analysis is the process of identifying and measuring biomarkers, which are biological molecules or characteristics that can serve as indicators of a particular disease, condition, or physiological state. Biomarkers can provide valuable information on disease diagnosis, prognosis, and treatment response, and can help tailor treatment options to individual patients.
The global biomarker analysis market refers to the market for analyzing and measuring biomarkers, which are biological indicators that can be measured objectively and reliably to assess normal and pathological processes, biological response to treatment, or pharmacological responses. Biomarker analysis plays a critical role in various fields, including medical research, diagnostics, drug discovery, and personalized medicine.
Here are some key factors influencing the growth of the global biomarker analysis market:
Increasing prevalence of chronic diseases: Chronic diseases such as cancer, cardiovascular diseases, and neurological disorders are a significant burden on healthcare systems worldwide. Biomarker analysis plays a crucial role in the early detection, diagnosis, and monitoring of these diseases. The growing prevalence of chronic diseases is driving the demand for biomarker analysis tools and technologies.
Advancements in genomics and proteomics: The field of genomics and proteomics has seen significant advancements in recent years, enabling the identification and analysis of a wide range of biomarkers. Next-generation sequencing (NGS), mass spectrometry, microarray technologies, and other high-throughput techniques have revolutionized biomarker analysis. The increasing adoption of these advanced technologies is fueling the growth of the biomarker analysis market.
Personalized medicine and companion diagnostics: Biomarker analysis is integral to personalized medicine, which involves tailoring medical treatment to an individual’s genetic makeup, lifestyle, and specific biomarkers. Biomarkers are used for patient stratification, treatment selection, and monitoring treatment response. The rising focus on personalized medicine, coupled with the development of companion diagnostics, is driving the demand for biomarker analysis tools and services.
Drug discovery and development: Biomarker analysis is essential in the drug discovery and development process. Biomarkers are used to identify potential drug targets, assess drug efficacy and safety, and predict patient response to therapy. Pharmaceutical companies, research institutions, and contract research organizations (CROs) utilize biomarker analysis to guide the development of new drugs and therapies. The increasing investment in drug discovery and development activities is boosting the demand for biomarker analysis technologies.
Technological advancements and automation: The biomarker analysis field has witnessed significant technological advancements in recent years. Automated platforms, high-throughput screening systems, and analytical instruments have made biomarker analysis more efficient, accurate, and reproducible. These technological advancements have improved the workflow in biomarker analysis laboratories and reduced turnaround times, driving market growth.
The global biomarker analysis market can be segmented based on type (genetic biomarkers, protein biomarkers, metabolomic biomarkers, imaging biomarkers, and others), application (diagnostics, drug discovery and development, personalized medicine, and others), end-user (hospitals and diagnostic laboratories, pharmaceutical and biotechnology companies, research institutions, and CROs), and geography (North America, Europe, Asia Pacific, Latin America, and the Middle East and Africa).
In summary, the global biomarker analysis market is driven by the increasing prevalence of chronic diseases, advancements in genomics and proteomics, personalized medicine approaches, drug discovery and development efforts, and technological advancements in biomarker analysis techniques. The market is expected to witness substantial growth as biomarker analysis continues to play a crucial role in medical research, diagnostics, and drug development, enabling personalized and targeted healthcare approaches.The global biomarker analysis market refers to the market for analyzing and measuring biomarkers, which are biological indicators that can be measured objectively and reliably to assess normal and pathological processes, biological response to treatment, or pharmacological responses. Biomarker analysis plays a critical role in various fields, including medical research, diagnostics, drug discovery, and personalized medicine.
Here are some key factors influencing the growth of the global biomarker analysis market:
Increasing prevalence of chronic diseases: Chronic diseases such as cancer, cardiovascular diseases, and neurological disorders are a significant burden on healthcare systems worldwide. Biomarker analysis plays a crucial role in the early detection, diagnosis, and monitoring of these diseases. The growing prevalence of chronic diseases is driving the demand for biomarker analysis tools and technologies.
Advancements in genomics and proteomics: The field of genomics and proteomics has seen significant advancements in recent years, enabling the identification and analysis of a wide range of biomarkers. Next-generation sequencing (NGS), mass spectrometry, microarray technologies, and other high-throughput techniques have revolutionized biomarker analysis. The increasing adoption of these advanced technologies is fueling the growth of the biomarker analysis market.
Personalized medicine and companion diagnostics: Biomarker analysis is integral to personalized medicine, which involves tailoring medical treatment to an individual’s genetic makeup, lifestyle, and specific biomarkers. Biomarkers are used for patient stratification, treatment selection, and monitoring treatment response. The rising focus on personalized medicine, coupled with the development of companion diagnostics, is driving the demand for biomarker analysis tools and services.
Drug discovery and development: Biomarker analysis is essential in the drug discovery and development process. Biomarkers are used to identify potential drug targets, assess drug efficacy and safety, and predict patient response to therapy. Pharmaceutical companies, research institutions, and contract research organizations (CROs) utilize biomarker analysis to guide the development of new drugs and therapies. The increasing investment in drug discovery and development activities is boosting the demand for biomarker analysis technologies.
Technological advancements and automation: The biomarker analysis field has witnessed significant technological advancements in recent years. Automated platforms, high-throughput screening systems, and analytical instruments have made biomarker analysis more efficient, accurate, and reproducible. These technological advancements have improved the workflow in biomarker analysis laboratories and reduced turnaround times, driving market growth.
The global biomarker analysis market can be segmented based on type (genetic biomarkers, protein biomarkers, metabolomic biomarkers, imaging biomarkers, and others), application (diagnostics, drug discovery and development, personalized medicine, and others), end-user (hospitals and diagnostic laboratories, pharmaceutical and biotechnology companies, research institutions, and CROs), and geography (North America, Europe, Asia Pacific, Latin America, and the Middle East and Africa).
In summary, the global biomarker analysis market is driven by the increasing prevalence of chronic diseases, advancements in genomics and proteomics, personalized medicine approaches, drug discovery and development efforts, and technological advancements in biomarker analysis techniques. The market is expected to witness substantial growth as biomarker analysis continues to play a crucial role in medical research, diagnostics, and drug development, enabling personalized and targeted healthcare approaches.
This report aims to provide a comprehensive presentation of the global market for Biomarker Analysis, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Biomarker Analysis.
The Biomarker Analysis market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Biomarker Analysis market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Biomarker Analysis companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation

Scope of Biomarker Analysis Market Report

Report Metric Details
Report Name Biomarker Analysis Market
Accounted market size in year US$ 4275 million
Forecasted market size in 2031 US$ 8788 million
CAGR 11.0%
Base Year year
Forecasted years 2025 - 2031
Segment by Type
Segment by Application
  • Diagnosis
  • Prognosis
  • Treatment Selection
  • Monitoring
  • Clinical Trials
By Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company Bio-Rad, Eurofins Scientific, Crown Bioscience, Meridian Bioscience, Thermo Fisher Scientific Inc., Siemens Healthineers, Roche Molecular Diagnostics, Abbott Laboratories, Agilent/Dako, Becton, Dickinson and Company, Eve Technologies, Fluidic Analytics, Hybrigenics Services, Luminex Corp, Qiagen
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
  • Chapter 3: Detailed analysis of Biomarker Analysis company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
  • Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 12: The main points and conclusions of the report.

FAQ for this report

How fast is Biomarker Analysis Market growing?

Ans: The Biomarker Analysis Market witnessing a CAGR of 11.0% during the forecast period 2025-2031.

What is the Biomarker Analysis Market size in 2031?

Ans: The Biomarker Analysis Market size in 2031 will be US$ 8788 million.

Who are the main players in the Biomarker Analysis Market report?

Ans: The main players in the Biomarker Analysis Market are Bio-Rad, Eurofins Scientific, Crown Bioscience, Meridian Bioscience, Thermo Fisher Scientific Inc., Siemens Healthineers, Roche Molecular Diagnostics, Abbott Laboratories, Agilent/Dako, Becton, Dickinson and Company, Eve Technologies, Fluidic Analytics, Hybrigenics Services, Luminex Corp, Qiagen

What are the Application segmentation covered in the Biomarker Analysis Market report?

Ans: The Applications covered in the Biomarker Analysis Market report are Diagnosis, Prognosis, Treatment Selection, Monitoring, Clinical Trials

What are the Type segmentation covered in the Biomarker Analysis Market report?

Ans: The Types covered in the Biomarker Analysis Market report are Diagnostic Biomarkers, Prognostic Biomarkers, Predictive Biomarkers, Safety Biomarkers, Surrogate Biomarkers

Recommended Reports

Biomarker Technologies

Diagnostics & Analyzers

Hematology & Genetic

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Biomarker Analysis Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Diagnostic Biomarkers
1.2.3 Prognostic Biomarkers
1.2.4 Predictive Biomarkers
1.2.5 Safety Biomarkers
1.2.6 Surrogate Biomarkers
1.3 Market by Application
1.3.1 Global Biomarker Analysis Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Diagnosis
1.3.3 Prognosis
1.3.4 Treatment Selection
1.3.5 Monitoring
1.3.6 Clinical Trials
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Biomarker Analysis Market Perspective (2020-2031)
2.2 Global Biomarker Analysis Growth Trends by Region
2.2.1 Global Biomarker Analysis Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Biomarker Analysis Historic Market Size by Region (2020-2025)
2.2.3 Biomarker Analysis Forecasted Market Size by Region (2026-2031)
2.3 Biomarker Analysis Market Dynamics
2.3.1 Biomarker Analysis Industry Trends
2.3.2 Biomarker Analysis Market Drivers
2.3.3 Biomarker Analysis Market Challenges
2.3.4 Biomarker Analysis Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Biomarker Analysis Players by Revenue
3.1.1 Global Top Biomarker Analysis Players by Revenue (2020-2025)
3.1.2 Global Biomarker Analysis Revenue Market Share by Players (2020-2025)
3.2 Global Biomarker Analysis Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Biomarker Analysis Revenue
3.4 Global Biomarker Analysis Market Concentration Ratio
3.4.1 Global Biomarker Analysis Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Biomarker Analysis Revenue in 2024
3.5 Global Key Players of Biomarker Analysis Head office and Area Served
3.6 Global Key Players of Biomarker Analysis, Product and Application
3.7 Global Key Players of Biomarker Analysis, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Biomarker Analysis Breakdown Data by Type
4.1 Global Biomarker Analysis Historic Market Size by Type (2020-2025)
4.2 Global Biomarker Analysis Forecasted Market Size by Type (2026-2031)
5 Biomarker Analysis Breakdown Data by Application
5.1 Global Biomarker Analysis Historic Market Size by Application (2020-2025)
5.2 Global Biomarker Analysis Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America Biomarker Analysis Market Size (2020-2031)
6.2 North America Biomarker Analysis Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Biomarker Analysis Market Size by Country (2020-2025)
6.4 North America Biomarker Analysis Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Biomarker Analysis Market Size (2020-2031)
7.2 Europe Biomarker Analysis Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Biomarker Analysis Market Size by Country (2020-2025)
7.4 Europe Biomarker Analysis Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Biomarker Analysis Market Size (2020-2031)
8.2 Asia-Pacific Biomarker Analysis Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Biomarker Analysis Market Size by Region (2020-2025)
8.4 Asia-Pacific Biomarker Analysis Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Biomarker Analysis Market Size (2020-2031)
9.2 Latin America Biomarker Analysis Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Biomarker Analysis Market Size by Country (2020-2025)
9.4 Latin America Biomarker Analysis Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Biomarker Analysis Market Size (2020-2031)
10.2 Middle East & Africa Biomarker Analysis Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Biomarker Analysis Market Size by Country (2020-2025)
10.4 Middle East & Africa Biomarker Analysis Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Bio-Rad
11.1.1 Bio-Rad Company Details
11.1.2 Bio-Rad Business Overview
11.1.3 Bio-Rad Biomarker Analysis Introduction
11.1.4 Bio-Rad Revenue in Biomarker Analysis Business (2020-2025)
11.1.5 Bio-Rad Recent Development
11.2 Eurofins Scientific
11.2.1 Eurofins Scientific Company Details
11.2.2 Eurofins Scientific Business Overview
11.2.3 Eurofins Scientific Biomarker Analysis Introduction
11.2.4 Eurofins Scientific Revenue in Biomarker Analysis Business (2020-2025)
11.2.5 Eurofins Scientific Recent Development
11.3 Crown Bioscience
11.3.1 Crown Bioscience Company Details
11.3.2 Crown Bioscience Business Overview
11.3.3 Crown Bioscience Biomarker Analysis Introduction
11.3.4 Crown Bioscience Revenue in Biomarker Analysis Business (2020-2025)
11.3.5 Crown Bioscience Recent Development
11.4 Meridian Bioscience
11.4.1 Meridian Bioscience Company Details
11.4.2 Meridian Bioscience Business Overview
11.4.3 Meridian Bioscience Biomarker Analysis Introduction
11.4.4 Meridian Bioscience Revenue in Biomarker Analysis Business (2020-2025)
11.4.5 Meridian Bioscience Recent Development
11.5 Thermo Fisher Scientific Inc.
11.5.1 Thermo Fisher Scientific Inc. Company Details
11.5.2 Thermo Fisher Scientific Inc. Business Overview
11.5.3 Thermo Fisher Scientific Inc. Biomarker Analysis Introduction
11.5.4 Thermo Fisher Scientific Inc. Revenue in Biomarker Analysis Business (2020-2025)
11.5.5 Thermo Fisher Scientific Inc. Recent Development
11.6 Siemens Healthineers
11.6.1 Siemens Healthineers Company Details
11.6.2 Siemens Healthineers Business Overview
11.6.3 Siemens Healthineers Biomarker Analysis Introduction
11.6.4 Siemens Healthineers Revenue in Biomarker Analysis Business (2020-2025)
11.6.5 Siemens Healthineers Recent Development
11.7 Roche Molecular Diagnostics
11.7.1 Roche Molecular Diagnostics Company Details
11.7.2 Roche Molecular Diagnostics Business Overview
11.7.3 Roche Molecular Diagnostics Biomarker Analysis Introduction
11.7.4 Roche Molecular Diagnostics Revenue in Biomarker Analysis Business (2020-2025)
11.7.5 Roche Molecular Diagnostics Recent Development
11.8 Abbott Laboratories
11.8.1 Abbott Laboratories Company Details
11.8.2 Abbott Laboratories Business Overview
11.8.3 Abbott Laboratories Biomarker Analysis Introduction
11.8.4 Abbott Laboratories Revenue in Biomarker Analysis Business (2020-2025)
11.8.5 Abbott Laboratories Recent Development
11.9 Agilent/Dako
11.9.1 Agilent/Dako Company Details
11.9.2 Agilent/Dako Business Overview
11.9.3 Agilent/Dako Biomarker Analysis Introduction
11.9.4 Agilent/Dako Revenue in Biomarker Analysis Business (2020-2025)
11.9.5 Agilent/Dako Recent Development
11.10 Becton, Dickinson and Company
11.10.1 Becton, Dickinson and Company Company Details
11.10.2 Becton, Dickinson and Company Business Overview
11.10.3 Becton, Dickinson and Company Biomarker Analysis Introduction
11.10.4 Becton, Dickinson and Company Revenue in Biomarker Analysis Business (2020-2025)
11.10.5 Becton, Dickinson and Company Recent Development
11.11 Eve Technologies
11.11.1 Eve Technologies Company Details
11.11.2 Eve Technologies Business Overview
11.11.3 Eve Technologies Biomarker Analysis Introduction
11.11.4 Eve Technologies Revenue in Biomarker Analysis Business (2020-2025)
11.11.5 Eve Technologies Recent Development
11.12 Fluidic Analytics
11.12.1 Fluidic Analytics Company Details
11.12.2 Fluidic Analytics Business Overview
11.12.3 Fluidic Analytics Biomarker Analysis Introduction
11.12.4 Fluidic Analytics Revenue in Biomarker Analysis Business (2020-2025)
11.12.5 Fluidic Analytics Recent Development
11.13 Hybrigenics Services
11.13.1 Hybrigenics Services Company Details
11.13.2 Hybrigenics Services Business Overview
11.13.3 Hybrigenics Services Biomarker Analysis Introduction
11.13.4 Hybrigenics Services Revenue in Biomarker Analysis Business (2020-2025)
11.13.5 Hybrigenics Services Recent Development
11.14 Luminex Corp
11.14.1 Luminex Corp Company Details
11.14.2 Luminex Corp Business Overview
11.14.3 Luminex Corp Biomarker Analysis Introduction
11.14.4 Luminex Corp Revenue in Biomarker Analysis Business (2020-2025)
11.14.5 Luminex Corp Recent Development
11.15 Qiagen
11.15.1 Qiagen Company Details
11.15.2 Qiagen Business Overview
11.15.3 Qiagen Biomarker Analysis Introduction
11.15.4 Qiagen Revenue in Biomarker Analysis Business (2020-2025)
11.15.5 Qiagen Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
FEATURED COMPANIES
Bio Rad
Eurofins Scientific
Crown Bioscience
Meridian Bioscience
Thermo Fisher Scientific Inc
Siemens Healthineers
Roche Molecular Diagnostics
Abbott Laboratories
Becton Dickinson and Company
Eve Technologies
Hybrigenics Services
Luminex Corp
Qiagen NV
Agilent/Dako
Fluidic Analytics
List of Tables
 Table 1. Global Biomarker Analysis Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
 Table 2. Key Players of Diagnostic Biomarkers
 Table 3. Key Players of Prognostic Biomarkers
 Table 4. Key Players of Predictive Biomarkers
 Table 5. Key Players of Safety Biomarkers
 Table 6. Key Players of Surrogate Biomarkers
 Table 7. Global Biomarker Analysis Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
 Table 8. Global Biomarker Analysis Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 9. Global Biomarker Analysis Market Size by Region (2020-2025) & (US$ Million)
 Table 10. Global Biomarker Analysis Market Share by Region (2020-2025)
 Table 11. Global Biomarker Analysis Forecasted Market Size by Region (2026-2031) & (US$ Million)
 Table 12. Global Biomarker Analysis Market Share by Region (2026-2031)
 Table 13. Biomarker Analysis Market Trends
 Table 14. Biomarker Analysis Market Drivers
 Table 15. Biomarker Analysis Market Challenges
 Table 16. Biomarker Analysis Market Restraints
 Table 17. Global Biomarker Analysis Revenue by Players (2020-2025) & (US$ Million)
 Table 18. Global Biomarker Analysis Market Share by Players (2020-2025)
 Table 19. Global Top Biomarker Analysis Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Biomarker Analysis as of 2024)
 Table 20. Ranking of Global Top Biomarker Analysis Companies by Revenue (US$ Million) in 2024
 Table 21. Global 5 Largest Players Market Share by Biomarker Analysis Revenue (CR5 and HHI) & (2020-2025)
 Table 22. Global Key Players of Biomarker Analysis, Headquarters and Area Served
 Table 23. Global Key Players of Biomarker Analysis, Product and Application
 Table 24. Global Key Players of Biomarker Analysis, Date of Enter into This Industry
 Table 25. Mergers & Acquisitions, Expansion Plans
 Table 26. Global Biomarker Analysis Market Size by Type (2020-2025) & (US$ Million)
 Table 27. Global Biomarker Analysis Revenue Market Share by Type (2020-2025)
 Table 28. Global Biomarker Analysis Forecasted Market Size by Type (2026-2031) & (US$ Million)
 Table 29. Global Biomarker Analysis Revenue Market Share by Type (2026-2031)
 Table 30. Global Biomarker Analysis Market Size by Application (2020-2025) & (US$ Million)
 Table 31. Global Biomarker Analysis Revenue Market Share by Application (2020-2025)
 Table 32. Global Biomarker Analysis Forecasted Market Size by Application (2026-2031) & (US$ Million)
 Table 33. Global Biomarker Analysis Revenue Market Share by Application (2026-2031)
 Table 34. North America Biomarker Analysis Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 35. North America Biomarker Analysis Market Size by Country (2020-2025) & (US$ Million)
 Table 36. North America Biomarker Analysis Market Size by Country (2026-2031) & (US$ Million)
 Table 37. Europe Biomarker Analysis Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 38. Europe Biomarker Analysis Market Size by Country (2020-2025) & (US$ Million)
 Table 39. Europe Biomarker Analysis Market Size by Country (2026-2031) & (US$ Million)
 Table 40. Asia-Pacific Biomarker Analysis Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 41. Asia-Pacific Biomarker Analysis Market Size by Region (2020-2025) & (US$ Million)
 Table 42. Asia-Pacific Biomarker Analysis Market Size by Region (2026-2031) & (US$ Million)
 Table 43. Latin America Biomarker Analysis Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 44. Latin America Biomarker Analysis Market Size by Country (2020-2025) & (US$ Million)
 Table 45. Latin America Biomarker Analysis Market Size by Country (2026-2031) & (US$ Million)
 Table 46. Middle East & Africa Biomarker Analysis Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 47. Middle East & Africa Biomarker Analysis Market Size by Country (2020-2025) & (US$ Million)
 Table 48. Middle East & Africa Biomarker Analysis Market Size by Country (2026-2031) & (US$ Million)
 Table 49. Bio-Rad Company Details
 Table 50. Bio-Rad Business Overview
 Table 51. Bio-Rad Biomarker Analysis Product
 Table 52. Bio-Rad Revenue in Biomarker Analysis Business (2020-2025) & (US$ Million)
 Table 53. Bio-Rad Recent Development
 Table 54. Eurofins Scientific Company Details
 Table 55. Eurofins Scientific Business Overview
 Table 56. Eurofins Scientific Biomarker Analysis Product
 Table 57. Eurofins Scientific Revenue in Biomarker Analysis Business (2020-2025) & (US$ Million)
 Table 58. Eurofins Scientific Recent Development
 Table 59. Crown Bioscience Company Details
 Table 60. Crown Bioscience Business Overview
 Table 61. Crown Bioscience Biomarker Analysis Product
 Table 62. Crown Bioscience Revenue in Biomarker Analysis Business (2020-2025) & (US$ Million)
 Table 63. Crown Bioscience Recent Development
 Table 64. Meridian Bioscience Company Details
 Table 65. Meridian Bioscience Business Overview
 Table 66. Meridian Bioscience Biomarker Analysis Product
 Table 67. Meridian Bioscience Revenue in Biomarker Analysis Business (2020-2025) & (US$ Million)
 Table 68. Meridian Bioscience Recent Development
 Table 69. Thermo Fisher Scientific Inc. Company Details
 Table 70. Thermo Fisher Scientific Inc. Business Overview
 Table 71. Thermo Fisher Scientific Inc. Biomarker Analysis Product
 Table 72. Thermo Fisher Scientific Inc. Revenue in Biomarker Analysis Business (2020-2025) & (US$ Million)
 Table 73. Thermo Fisher Scientific Inc. Recent Development
 Table 74. Siemens Healthineers Company Details
 Table 75. Siemens Healthineers Business Overview
 Table 76. Siemens Healthineers Biomarker Analysis Product
 Table 77. Siemens Healthineers Revenue in Biomarker Analysis Business (2020-2025) & (US$ Million)
 Table 78. Siemens Healthineers Recent Development
 Table 79. Roche Molecular Diagnostics Company Details
 Table 80. Roche Molecular Diagnostics Business Overview
 Table 81. Roche Molecular Diagnostics Biomarker Analysis Product
 Table 82. Roche Molecular Diagnostics Revenue in Biomarker Analysis Business (2020-2025) & (US$ Million)
 Table 83. Roche Molecular Diagnostics Recent Development
 Table 84. Abbott Laboratories Company Details
 Table 85. Abbott Laboratories Business Overview
 Table 86. Abbott Laboratories Biomarker Analysis Product
 Table 87. Abbott Laboratories Revenue in Biomarker Analysis Business (2020-2025) & (US$ Million)
 Table 88. Abbott Laboratories Recent Development
 Table 89. Agilent/Dako Company Details
 Table 90. Agilent/Dako Business Overview
 Table 91. Agilent/Dako Biomarker Analysis Product
 Table 92. Agilent/Dako Revenue in Biomarker Analysis Business (2020-2025) & (US$ Million)
 Table 93. Agilent/Dako Recent Development
 Table 94. Becton, Dickinson and Company Company Details
 Table 95. Becton, Dickinson and Company Business Overview
 Table 96. Becton, Dickinson and Company Biomarker Analysis Product
 Table 97. Becton, Dickinson and Company Revenue in Biomarker Analysis Business (2020-2025) & (US$ Million)
 Table 98. Becton, Dickinson and Company Recent Development
 Table 99. Eve Technologies Company Details
 Table 100. Eve Technologies Business Overview
 Table 101. Eve Technologies Biomarker Analysis Product
 Table 102. Eve Technologies Revenue in Biomarker Analysis Business (2020-2025) & (US$ Million)
 Table 103. Eve Technologies Recent Development
 Table 104. Fluidic Analytics Company Details
 Table 105. Fluidic Analytics Business Overview
 Table 106. Fluidic Analytics Biomarker Analysis Product
 Table 107. Fluidic Analytics Revenue in Biomarker Analysis Business (2020-2025) & (US$ Million)
 Table 108. Fluidic Analytics Recent Development
 Table 109. Hybrigenics Services Company Details
 Table 110. Hybrigenics Services Business Overview
 Table 111. Hybrigenics Services Biomarker Analysis Product
 Table 112. Hybrigenics Services Revenue in Biomarker Analysis Business (2020-2025) & (US$ Million)
 Table 113. Hybrigenics Services Recent Development
 Table 114. Luminex Corp Company Details
 Table 115. Luminex Corp Business Overview
 Table 116. Luminex Corp Biomarker Analysis Product
 Table 117. Luminex Corp Revenue in Biomarker Analysis Business (2020-2025) & (US$ Million)
 Table 118. Luminex Corp Recent Development
 Table 119. Qiagen Company Details
 Table 120. Qiagen Business Overview
 Table 121. Qiagen Biomarker Analysis Product
 Table 122. Qiagen Revenue in Biomarker Analysis Business (2020-2025) & (US$ Million)
 Table 123. Qiagen Recent Development
 Table 124. Research Programs/Design for This Report
 Table 125. Key Data Information from Secondary Sources
 Table 126. Key Data Information from Primary Sources
 Table 127. Authors List of This Report


List of Figures
 Figure 1. Biomarker Analysis Picture
 Figure 2. Global Biomarker Analysis Market Size Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global Biomarker Analysis Market Share by Type: 2024 VS 2031
 Figure 4. Diagnostic Biomarkers Features
 Figure 5. Prognostic Biomarkers Features
 Figure 6. Predictive Biomarkers Features
 Figure 7. Safety Biomarkers Features
 Figure 8. Surrogate Biomarkers Features
 Figure 9. Global Biomarker Analysis Market Size by Application (2020-2031) & (US$ Million)
 Figure 10. Global Biomarker Analysis Market Share by Application: 2024 VS 2031
 Figure 11. Diagnosis Case Studies
 Figure 12. Prognosis Case Studies
 Figure 13. Treatment Selection Case Studies
 Figure 14. Monitoring Case Studies
 Figure 15. Clinical Trials Case Studies
 Figure 16. Biomarker Analysis Report Years Considered
 Figure 17. Global Biomarker Analysis Market Size (US$ Million), Year-over-Year: 2020-2031
 Figure 18. Global Biomarker Analysis Market Size, (US$ Million), 2020 VS 2024 VS 2031
 Figure 19. Global Biomarker Analysis Market Share by Region: 2024 VS 2031
 Figure 20. Global Biomarker Analysis Market Share by Players in 2024
 Figure 21. Global Top Biomarker Analysis Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Biomarker Analysis as of 2024)
 Figure 22. The Top 10 and 5 Players Market Share by Biomarker Analysis Revenue in 2024
 Figure 23. North America Biomarker Analysis Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 24. North America Biomarker Analysis Market Share by Country (2020-2031)
 Figure 25. United States Biomarker Analysis Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 26. Canada Biomarker Analysis Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 27. Europe Biomarker Analysis Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 28. Europe Biomarker Analysis Market Share by Country (2020-2031)
 Figure 29. Germany Biomarker Analysis Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 30. France Biomarker Analysis Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 31. U.K. Biomarker Analysis Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 32. Italy Biomarker Analysis Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 33. Russia Biomarker Analysis Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 34. Nordic Countries Biomarker Analysis Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 35. Asia-Pacific Biomarker Analysis Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 36. Asia-Pacific Biomarker Analysis Market Share by Region (2020-2031)
 Figure 37. China Biomarker Analysis Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 38. Japan Biomarker Analysis Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 39. South Korea Biomarker Analysis Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 40. Southeast Asia Biomarker Analysis Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 41. India Biomarker Analysis Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 42. Australia Biomarker Analysis Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 43. Latin America Biomarker Analysis Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 44. Latin America Biomarker Analysis Market Share by Country (2020-2031)
 Figure 45. Mexico Biomarker Analysis Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 46. Brazil Biomarker Analysis Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 47. Middle East & Africa Biomarker Analysis Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 48. Middle East & Africa Biomarker Analysis Market Share by Country (2020-2031)
 Figure 49. Turkey Biomarker Analysis Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 50. Saudi Arabia Biomarker Analysis Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 51. UAE Biomarker Analysis Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 52. Bio-Rad Revenue Growth Rate in Biomarker Analysis Business (2020-2025)
 Figure 53. Eurofins Scientific Revenue Growth Rate in Biomarker Analysis Business (2020-2025)
 Figure 54. Crown Bioscience Revenue Growth Rate in Biomarker Analysis Business (2020-2025)
 Figure 55. Meridian Bioscience Revenue Growth Rate in Biomarker Analysis Business (2020-2025)
 Figure 56. Thermo Fisher Scientific Inc. Revenue Growth Rate in Biomarker Analysis Business (2020-2025)
 Figure 57. Siemens Healthineers Revenue Growth Rate in Biomarker Analysis Business (2020-2025)
 Figure 58. Roche Molecular Diagnostics Revenue Growth Rate in Biomarker Analysis Business (2020-2025)
 Figure 59. Abbott Laboratories Revenue Growth Rate in Biomarker Analysis Business (2020-2025)
 Figure 60. Agilent/Dako Revenue Growth Rate in Biomarker Analysis Business (2020-2025)
 Figure 61. Becton, Dickinson and Company Revenue Growth Rate in Biomarker Analysis Business (2020-2025)
 Figure 62. Eve Technologies Revenue Growth Rate in Biomarker Analysis Business (2020-2025)
 Figure 63. Fluidic Analytics Revenue Growth Rate in Biomarker Analysis Business (2020-2025)
 Figure 64. Hybrigenics Services Revenue Growth Rate in Biomarker Analysis Business (2020-2025)
 Figure 65. Luminex Corp Revenue Growth Rate in Biomarker Analysis Business (2020-2025)
 Figure 66. Qiagen Revenue Growth Rate in Biomarker Analysis Business (2020-2025)
 Figure 67. Bottom-up and Top-down Approaches for This Report
 Figure 68. Data Triangulation
 Figure 69. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Lukasiewicz Research Network

SIMILAR REPORTS

Global Biomarker Market Research Report 2024
Global Biomarker Detection Systems Market Research Report 2024
Global Commercializing Biomarkers in Therapeutic and Diagnostic Applications Market Insights Forecast to 2030
Global Commercializing Biomarkers Market Research Report 2025
Global Clinical Biomarker Testing Market Research Report 2024
Medical Biomarkers Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Brain Biomarker Market Research Report 2024
Protein Diagnostics Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Oncology Biomarker Market Insights Forecast to 2030
Global Diagnostic Biomarker Market Research Report 2024
Global Cancer Biomarker Market Insights Forecast to 2030
Proteomic Biomarker Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Clinical Biomarkers Market Research Report 2024
Global Targeted Biomarker Market Insights Forecast to 2030
Global Digital Biomarker Market Research Report 2025
Biological Information Analysis System Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Cardiac Biomarkers Testing Market Insights Forecast to 2030
Global Protein Characterization and Identification Market Insights Forecast to 2030
Renal Biomarkers Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Cancer Molecular Biomarkers Market Research Report 2024

RELATED REPORTS

Global Pharma and Healthcare Social Media Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-14Y6812
Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Food Additives Testing Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-34O3983
Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Gabapentin API Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-9V17601
Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Electronic Informed Consent Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-22C17047
Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions